Medtech: startup speed, hospital clocks

A medtech startup measures time in months of runway. A hospital system measures it in committee cycles. Between a first conversation and a signed agreement sit clinical review, a value analysis committee that meets monthly at best, IT and security review, and a procurement process built to slow things down on purpose. The product might be urgent. The buying process has never heard of urgency. Medtech outbound is the craft of selling across that gap without pretending it is not there.

The clock mismatch, honestly stated

The trap is not the long cycle itself. It is planning as if the cycle were shorter. A founder who starts outbound expecting meetings in month one to become revenue in month four has built a plan the buyer's calendar will not honor, and the disappointment usually gets blamed on the rep, the message, or the channel, none of which caused it. Committee time is a structural fact of the vertical, the purest case of a rule we wrote about in cycle length changes everything upstream: the longer the cycle, the earlier pipeline work has to start and the longer it must be sustained before judgment day means anything.

The mismatch also changes what a first meeting is for. In a velocity business, the first meeting starts a sales process. In medtech, it starts a relationship that will need to survive six months of internal machinery. Which means the real work is rarely convincing the person in the room. It is equipping that person to convince a committee you will never attend, the discipline we covered in champions are made, not found. The clinician or department lead who takes your meeting becomes your proxy in the value analysis discussion, and everything you hand them, the one-page summary, the evidence, the answers to the five questions they will be asked, is you showing up to a meeting you are not invited to.

The early-conversation discipline

Three practices follow from the clocks. Start conversations before the buying window, not inside it. By the time a system announces an initiative, its shortlist is largely formed, so the accounts worth calling this quarter are the ones whose committees will convene two or three quarters from now. Count progress in stages, not weeks. A deal that cleared clinical review on schedule is on track even when the calendar feels glacial, and a funnel report that only counts meetings and closes will misread the whole quarter. And prepare for the late-stage gauntlet early: when procurement enters the room, the vendors who survive are the ones whose champion was armed months earlier.

None of this removes the tension with runway. It prices it. A medtech company that knows the honest cycle can decide, with open eyes, how many quarters of sustained outbound the balance sheet supports, instead of discovering the answer by quitting in month five, right before the committee season it paid to reach.

Healthcare and medtech is one of the six verticals we work in at CommandVA, and the reps who call it are trained for committee-time selling: early conversations, champion equipment, stage-based reporting that tells the truth about a long cycle. If your burn rate and your buyers' calendars are having an argument, book a strategy call. We will map your funnel against the committee clock and give you an honest read on the quarters between here and revenue.